Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty

被引:32
作者
Holland, Edward J. [1 ]
Lane, Stephen S. [2 ]
Kim, Terry [3 ]
Raizman, Michael [4 ]
Dunn, Steven [5 ]
机构
[1] Cincinnati Eye Inst, Edgewood, KY USA
[2] Assoc Eye Care, Stillwater, MN USA
[3] Duke Univ, Ctr Eye, Durham, NC USA
[4] Ophthalm Consultants Boston, Boston, MA USA
[5] Michigan Cornea Consultants, Southfield, MI USA
关键词
ocular penetration; ocular pharmacokinetics; gatifloxacin; moxifloxacin; keratoplasty;
D O I
10.1097/ICO.0b013e3181608561
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To compare the corneal and aqueous penetration and pharmacokinetics of gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions and their effect on corneal reepithelialization after penetrating keratoplasty. Methods: In this randomized, open-label, parallel-controlled study, corneal and aqueous penetration and the pharmacokinetic parameters of topically applied gatifloxacin 0.3% and moxifloxacin 0.5% (2 preoperative doses of I drop given 5 minutes apart) were estimated by using a sparse sampling method. Corneal and aqueous samples were collected 0.25, 0.5. 1, or 2 hours after the final dose. The concentration was determined by a high-performance liquid chromatography method. Stromal C-max:MBC50 (maximum drug concentration in serum to 50% minimum bactericidal concentration) ratios for selected ocular pathogens were also assessed. Postoperative corneal reepithelialization at days 1, 3, and 7 was evaluated and compared between groups. Results: The calculated pharmacokinetic parameters were higher with moxifloxacin 0.5% than with gatifloxacin 0.3%. The stromal C-max was 48.5 versus 15.7 mu g/g (P = 0.04), and the stromal AUC(0-2) (area under the concentration-time curve from 0 to 2 hours) was 30.9 versus 13.6 mu g center dot h/g (P < 0.05). The endothelial C-max was 76.1 versus 7.3 mu g/g (P > 0.05), and the endothelial AUC(0-2) was 43.9 versus 9.8 mu g-h/g (P < 0.05). The aqueous C-max was 0.9 versus 0.3 mu g/mL (P > 0.05), and the aqueous AUC(0-2) was 1.2 versus 0.4 mu g center dot h/mL (P < 0.05). Stromal C-max:MBC50 ratios were higher in the moxifloxacin 0.5% group for each pathogen tested. The corneal reepithelialization rates were comparable between groups. Conclusions: Topical preoperative moxifloxacin 0.5% achieved greater corneal and aqueous penetration than did gatifloxacin 0.3%. The clinical significance of this difference is not known. Postoperative use of these agents had similar effects on corneal reepithelialization.
引用
收藏
页码:314 / 319
页数:6
相关论文
共 32 条
[1]  
*ALC LAB, 2004, VIG MOX HYDR OPHTH S
[2]  
ALLERGAN, 2004, ZYMAR GATIFLOXACIN O
[3]   Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo [J].
Caballero, AR ;
Marquart, ME ;
O'Callaghan, RJ ;
Thibodeaux, BA ;
Johnston, KH ;
Dajcs, JJ .
CURRENT EYE RESEARCH, 2006, 31 (01) :23-29
[4]   Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis [J].
Dajcs, JJ ;
Thibodeaux, BA ;
Marquart, ME ;
Girgis, DO ;
Traidej, M ;
O'Callaghan, RJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) :1948-1952
[5]  
De Castro LEF, 2006, J OCUL PHARMACOL TH, V22, P132
[6]   Management of infectious keratitis following laser in situ keratomileusis [J].
Donnenfeld, ED ;
Kim, T ;
Holland, EJ ;
Azar, DT ;
Palmon, FR ;
Rubenstein, JB ;
Daya, S ;
Yoo, SH .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2005, 31 (10) :2008-2011
[7]  
Donnenfeld Robert S, 2006, Eye Contact Lens, V32, P46, DOI 10.1097/01.icl.0000174761.39015.34
[8]  
Eifrig CWG, 2002, OPHTHALMIC SURG LAS, V33, P373
[9]  
Han DP, 1996, AM J OPHTHALMOL, V122, P1
[10]   A study of corneal thickness, shape and collagen organisation in keratoconus using videokeratography and X-ray scattering techniques [J].
Hayes, Sally ;
Boote, Craig ;
Tuft, Stephen J. ;
Quantock, Andrew J. ;
Meek, Keith M. .
EXPERIMENTAL EYE RESEARCH, 2007, 84 (03) :423-434